Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02443389 · ClinicalTrials.gov registry record
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 2,186
- Enrollment target
NCT02443389 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 2,186 participants.
The verdict
NCT02443389 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 2,186 participants
- Enrollment target
Study Summary
Introduction: Based on single-center data, approximately 1 of every 3 newborns admitted to tertiary level neonatal intensive care units (NICU) develops acute kidney injury (AKI), and those with AKI have significantly worse outcomes. To stimulate discussion among researchers, the NIH NIDDK sponsored a workshop on neonatal AKI in April 2013. At that workshop, the group recognized the need to improve collaborations between neonatologists and nephrologists within and across centers. The investigators have created a multi-institutional, multi-disciplinary group, Neonatal Kidney Collaborative (NKC), in order to address the following critical needs identified at the workshop: AWAKEN is the inaugural study of this new collaboration. 1. Development of a standardized evidence-based definition of neonatal AKI 2. Evaluation of risk factors that predispose neonatal to AKI 3. Investigation into how fluid provision/ balance impacts biochemical and clinical outcomes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,186 participants |
| Start Date | 2015-03 |
| Est. Completion | 2016-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02443389
The ClinicalTrials.gov registry entry for NCT02443389 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,186 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02443389 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02443389 about?
NCT02443389 is a clinical study titled "Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates". Introduction: Based on single-center data, approximately 1 of every 3 newborns admitted to tertiary level neonatal intensive care units (NICU) develops acute kidney injury (AKI), and those with AKI have significantly worse outcomes. To stimulate discussion among researchers, the NIH NIDDK sponsored...
What is the current status of trial NCT02443389?
This trial is currently completed. The enrollment target is 2,186 participants. The study started on 2015-03. Estimated completion is 2016-03.
Who is sponsoring clinical trial NCT02443389?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.